https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=EAM-2201
EAM-2201 - 版本历史
2026-07-15T07:41:56Z
在这个wiki上该页的修订历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=EAM-2201&diff=4684813&oldid=prev
imported>Jimmy-bot：机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药
2025-08-15T10:24:16Z
<p>机器人: 尚未清空的已重定向分类） （<a href="/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&action=edit&redlink=1" class="new" title="Cat:狡詐家藥物（页面不存在）">Cat:狡詐家藥物</a>→<a href="/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&action=edit&redlink=1" class="new" title="Cat:策划药（页面不存在）">Cat:策划药</a></p>
<p><b>新页面</b></p><div>{{Infobox drug<br />
| IUPAC_name = (4-Ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1''H''-indol-3-yl]-methanone<br />
| image = EAM-2201_structure.png<br />
| width = 150<br />
<br />
<!--Clinical data--><br />
| tradename = <br />
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --><br />
| pregnancy_US = <!-- A / B / C / D / X --><br />
| pregnancy_category = <br />
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --><br />
| legal_BR = F2<br />
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-07-24 |title=RDC Nº 804 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 804 – Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |url-status=live |archive-url=https://web.archive.org/web/20230827163149/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |archive-date=2023-08-27 |access-date=2023-08-27 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-07-25}}</ref><br />
| legal_CA = Schedule II<br />
| legal_UK = PSA<br />
| legal_US = Schedule I<br />
| legal_DE = Anlage II<br />
| legal_NZ = Temporary Class<br />
| legal_status = <br />
| routes_of_administration =<br />
<br />
<!--Pharmacokinetic data--><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| elimination_half-life = <br />
| excretion =<br />
<br />
<!--Identifiers--><br />
| CAS_number_Ref = {{cascite|correct|??}}<br />
| CAS_number = 1364933-60-7<br />
| ATC_prefix = <br />
| UNII_Ref = {{fdacite|correct|FDA}}<br />
| UNII = OO52S1U9ET<br />
| ATC_suffix = <br />
| PubChem = 71308187 <br />
| ChemSpiderID = 29341514<br />
<br />
<!--Chemical data--><br />
| C=26 | H=26 | F=1 | N=1 | O=1 <br />
| smiles = CCC1=CC=C(C(C2=CN(CCCCCF)C3=C2C=CC=C3)=O)C4=C1C=CC=C4<br />
| StdInChI = 1S/C26H26FNO/c1-2-19-14-15-23(21-11-5-4-10-20(19)21)26(29)24-18-28(17-9-3-8-16-27)25-13-7-6-12-22(24)25/h4-7,10-15,18H,2-3,8-9,16-17H2,1H3<br />
| StdInChIKey = NSCXPXDWLZORPX-UHFFFAOYSA-N<br />
}}<br />
'''{{PAGENAME}}'''，化学名'''1-(5-氟戊基)-3-(4-乙基-1-萘甲酰基)吲哚'''，也称为'''4'-ethyl-[[AM-2201]]'''、'''5"-fluoro-[[JWH-210]]'''、'''SGT-14'''）是一种含氮[[有机氟化合物]]，化学式[[C26H26FNO|{{chem2|C26H26FNO}}]]，属于[[萘甲酰基吲哚]]类[[合成大麻素]]<ref>{{cite journal | vauthors = Kim JH, Kim HS, Kong TY, Lee JY, Kim JY, In MK, Lee HS | title = In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s | journal = Journal of Pharmaceutical and Biomedical Analysis | volume = 119 | issue = 5 | pages = 50–8 | date = February 2016 | pmid = 26641707 | doi = 10.1016/j.jpba.2015.11.023 }}</ref>，2015年列入《[[非药用类麻醉药品和精神药品名录]]》<ref>{{cite wikisource|wslink=关于印发《非药用类麻醉药品和精神药品列管办法》的通知|wslanguage=zh|title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知|publisher=公安部 国家卫生计生委 食品药品监管总局 国家禁毒办|year=2015|month=9|day=24}}</ref>。<br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
[[Category:大麻素]]<br />
[[Category:策划药]]<br />
[[Category:萘甲酰基吲哚]]<br />
[[Category:有机氟化合物]]<br />
[[Category:CB1受体激动剂]]<br />
[[Category:CB2受体激动剂]]</div>
imported>Jimmy-bot